• 533 Citations
  • 15 h-Index
19952020
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • Ph.D. (Phrmaceutical Science), National Taiwan University

Experience

  • 2016-2019 Director, Department of Pharmaceutical Sciences, Taipei Medical University
  • 2012- Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
  • 2007-2012 Assistant Professor, School of Pharmacy, Taipei Medical University
  • 2004-2007 Assistant Professor, Department of Biochemistry, Taipei Medical University

Research Interests

  • Discovery and Development of small molecules
  • Structure optimization through rational drug design
  • Isolation and modification of natural products

Fingerprint Dive into the research topics where Mei-Hsiang Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Coumarins Medicine & Life Sciences
Cells Chemical Compounds
Histone Deacetylases Medicine & Life Sciences
Rats Chemical Compounds
Derivatives Chemical Compounds
Cytotoxicity Chemical Compounds
Colonic Neoplasms Medicine & Life Sciences
Hydroxyl Radical Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2020

林美香-107研究計畫績效獎

Lin, M.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

108年度「藥品品質分析檢驗方法現代化」委託辦理計畫

Lin, M.

4/1/1912/1/19

Project: A - Government Institutionc - Ministry of Health and Welfare

設計及合成香豆素衍生物作為單羧酸轉運蛋白 MCTs抑制劑之活性研究

Lin, M.

7/1/172/28/18

Project: A - Government Institutionb - Ministry of Science and Technology

Synthesis and Antihyperglycemic Evaluation of Isosteviol Derivatives

Lin, M.

8/1/137/31/14

Project: A - Government Institutionb - Ministry of Science and Technology

Research Symposium for Chinese Medicine Research Projects

Liang, W., Huang, W. & Lin, M.

6/1/1212/15/12

Project: A - Government Institutionc - Ministry of Health and Welfare

Research Output 1995 2019

  • 533 Citations
  • 15 h-Index
  • 35 Article
5 Citations (Scopus)

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J. Y. & Liou, J. P., Jan 15 2019, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

Research output: Contribution to journalArticle

Benzamides
Histone Deacetylases
Tubulin
Heterografts
Inhibitory Concentration 50
Growth Inhibitors
Amides
Prostatic Neoplasms
Cells
Lead compounds
1 Citation (Scopus)

MPT0G413, A novel HDAC6-selective inhibitor, and bortezomib synergistically exert anti-tumor activity in multiple myeloma cells

Huang, F. I., Wu, Y. W., Sung, T. Y., Liou, J. P., Lin, M. H., Pan, S. L. & Yang, C. R., Jan 1 2019, In : Frontiers in Oncology. 9, APR, 249.

Research output: Contribution to journalArticle

Open Access
Histone Deacetylases
Multiple Myeloma
Neoplasms
Histone Deacetylase Inhibitors
Growth
1 Citation (Scopus)
Coumarins
Cell death
Colonic Neoplasms
Cell Death
Cells
1 Citation (Scopus)
Hemoglobin
hemoglobin
metabolism
liver
Metabolism